Latest news with #Ventas
Business Wire
28-05-2025
- Business
- Business Wire
Ventas Issues Business Update and Will Present at Nareit's REITweek 2025 Investor Conference
CHICAGO--(BUSINESS WIRE)--In conjunction with upcoming investor meetings, Ventas, Inc. (NYSE: VTR) (the 'Company,' 'Ventas') has issued a business update, which is available on the Company's website. In addition, the Company announced today that management will make a presentation at Nareit's REITweek 2025 Investor Conference (the 'Nareit Conference') on June 3, 2025, at 1:45 p.m. Eastern Time. The business update and Nareit Conference webcast and materials will be accessible on the Company's website at for a limited period. About Ventas Ventas, Inc. (NYSE: VTR) is a leading S&P 500 real estate investment trust enabling exceptional environments that benefit a large and growing aging population. With approximately 1,400 properties in North America and the United Kingdom, Ventas occupies an essential role in the longevity economy. The Company's growth is fueled by its approximately 850 senior housing communities, which provide valuable services to residents and enable them to thrive in supported environments. Ventas aims to deliver outsized performance by leveraging its operational expertise, data-driven insights from its Ventas OI TM platform, extensive relationships and strong financial position. The Ventas portfolio also includes outpatient medical buildings, research centers and healthcare facilities. Ventas's seasoned team of talented professionals shares a commitment to excellence, integrity and a common purpose of helping people live longer, healthier, happier lives.
Yahoo
14-05-2025
- Business
- Yahoo
Key Reasons to Add Ventas Stock to Your Portfolio Right Now
Ventas, Inc.'s VTR diverse portfolio of healthcare real estate assets is well-poised to capitalize on favorable industry fundamentals. An aging population and the rise in healthcare expenditure by senior citizens are likely to benefit the senior housing operating portfolio ('SHOP'). The outpatient medical portfolio is expected to gain from the favorable outpatient visit trends. The accretive investments to expand its research portfolio look promising. A healthy balance sheet position is likely to support its growth endeavors. Last month, this Chicago-based healthcare real estate investment trust ('REIT') reported first-quarter 2025 results. The company reported normalized funds from operations ('FFO') per share of 84 cents, beating the Zacks Consensus Estimate of 82 cents. The results reflected better-than-anticipated revenues. Ventas' same-store cash net operating income ('NOI') increased year over year. Shares of this Zacks Rank #2 (Buy) company have gained 1.6% over the past six months, against the industry's decline of 2.9%. Given the strength in its fundamentals, there seems to be additional room for growth of this stock. Image Source: Zacks Investment Research The senior citizen population is expected to rise in the years ahead. As a result, the national healthcare expenditure among senior citizens, who constitute a major customer base for healthcare services and incur higher healthcare expenditures than the average population, is likely to increase in the upcoming period. Notably, the U.S. population aged 80 years and above is expected to grow 28% in the next five years, driving significant demand for senior housing. In order to meet the rising demand, the company is expanding its SHOP portfolio by converting 45 large-scale senior housing communities (comprising about 5,700 units) from the triple net structure to SHOP. In 2025, Ventas expects its SHOP segment's same-store cash NOI to grow between 11% and 16%. Focus on OM&R Portfolio: Amid growing outpatient trends, Ventas is committed to capitalizing on this upside within its outpatient medical and research (OM&R) portfolio, which includes outpatient medical buildings and research centers. The growth in the population of people aged 65 years and above is driving the increase in outpatient visits, as they make three times more visits to the doctor than the general population. From 2020 to 2030, the 65+ population is expected to grow by approximately 28%. VTR's Accretive Investments: Ventas is carrying out accretive investments to enhance its research portfolio, which is essential for the delivery of crucial healthcare services and research related to life-saving vaccines and therapeutics. The company owns research centers in life science clusters, with a presence in some of the top-tier research university campuses. With top-rated tenants and long-term leases, its high-quality portfolio assures steady growth in cash flows. In the OM&R portfolio, Ventas generated 1.3% same-store cash NOI growth in the first quarter of 2025. Ventas expects the OM&R portfolio's same-store cash NOI to grow in the range of 2-3% in 2025. Balance Sheet Strength: Ventas maintains a healthy balance sheet position. The company has been making efforts to enhance its liquidity position and financial strength. As of March 31, 2025, the company had approximately $2.9 billion of liquidity. In April 2025, Ventas increased its liquidity to $3.6 billion by expanding its unsecured credit facility by $750 million. In first-quarter 2025, its net debt to further adjusted EBITDA improved to 5.7X year over year from 6.0X. Management expects continued leverage improvement in the balance of this year, driven by senior housing growth. Some other top-ranked stocks from the broader REIT sector are Cousins Properties CUZ and VICI Properties VICI, each carrying a Zacks Rank of 2 at present. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here. The Zacks Consensus Estimate for Cousins Properties' 2025 FFO per share is pegged at $2.79, which indicates year-over-year growth of 3.7%. The Zacks Consensus Estimate for VICI's full-year FFO per share is $2.34, which indicates an increase of 3.5% from the year-ago period. Note: Anything related to earnings presented in this write-up represents FFO, a widely used metric to gauge the performance of REITs. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Ventas, Inc. (VTR) : Free Stock Analysis Report Cousins Properties Incorporated (CUZ) : Free Stock Analysis Report VICI Properties Inc. (VICI) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research
Yahoo
14-05-2025
- Business
- Yahoo
Ventas (NYSE:VTR) Declares Quarterly Dividend of US$0.48 Per Share
Ventas announced a quarterly dividend and reported positive results for the first quarter, reflecting strong financial performance with sales and net income increases compared to the previous year. This announcement came during a period where the broader market, including indices such as the S&P 500 and Nasdaq, experienced a rally; this was largely driven by optimism around U.S.-China tariff reductions and encouraging inflation data. Ventas's price increase of 7% over the last quarter aligns with these market trends, where investor sentiment across various sectors was generally positive, underscoring the company's fiscal health. Every company has risks, and we've spotted 3 risks for Ventas (of which 1 is potentially serious!) you should know about. This technology could replace computers: discover the 22 stocks are working to make quantum computing a reality. The recent announcement of Ventas's quarterly dividend and positive first-quarter earnings highlights its strong financial footing amid broader market recovery. While the 7% share price increase aligns with positive market sentiment, the company's long-term total return of 137.55% over five years provides essential context. This substantial increase underscores Ventas's ability to generate value over extended periods, even as it faces challenges in the senior housing sector. Currently trading at US$65.83, the share price reflects investor confidence, yet it remains below the analyst consensus price target of US$75.95. In comparison to market and industry performance, Ventas's 1-year return surpassed that of both the US market, which returned 11.6%, and the US Health Care REITs industry, which returned 22.4%. This outperformance can be attributed to the company's strategic growth initiatives, including the expansion of its senior housing portfolio and integration of Brookdale communities. Analysts project an 8.8% annual revenue growth, driven by these strategic moves, potentially supporting forecasts of earnings reaching US$495.5 million by 2028. However, reliance on high occupancy rates remains a risk factor, impacting revenue and earnings projections. Ventas's share price movement and analyst forecasts suggest potential investment opportunities, although market conditions and operational challenges must be carefully considered. Jump into the full analysis health report here for a deeper understanding of Ventas. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include NYSE:VTR. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@
Yahoo
14-05-2025
- Business
- Yahoo
Ventas (NYSE:VTR) Declares Quarterly Dividend of US$0.48 Per Share
Ventas announced a quarterly dividend and reported positive results for the first quarter, reflecting strong financial performance with sales and net income increases compared to the previous year. This announcement came during a period where the broader market, including indices such as the S&P 500 and Nasdaq, experienced a rally; this was largely driven by optimism around U.S.-China tariff reductions and encouraging inflation data. Ventas's price increase of 7% over the last quarter aligns with these market trends, where investor sentiment across various sectors was generally positive, underscoring the company's fiscal health. Every company has risks, and we've spotted 3 risks for Ventas (of which 1 is potentially serious!) you should know about. This technology could replace computers: discover the 22 stocks are working to make quantum computing a reality. The recent announcement of Ventas's quarterly dividend and positive first-quarter earnings highlights its strong financial footing amid broader market recovery. While the 7% share price increase aligns with positive market sentiment, the company's long-term total return of 137.55% over five years provides essential context. This substantial increase underscores Ventas's ability to generate value over extended periods, even as it faces challenges in the senior housing sector. Currently trading at US$65.83, the share price reflects investor confidence, yet it remains below the analyst consensus price target of US$75.95. In comparison to market and industry performance, Ventas's 1-year return surpassed that of both the US market, which returned 11.6%, and the US Health Care REITs industry, which returned 22.4%. This outperformance can be attributed to the company's strategic growth initiatives, including the expansion of its senior housing portfolio and integration of Brookdale communities. Analysts project an 8.8% annual revenue growth, driven by these strategic moves, potentially supporting forecasts of earnings reaching US$495.5 million by 2028. However, reliance on high occupancy rates remains a risk factor, impacting revenue and earnings projections. Ventas's share price movement and analyst forecasts suggest potential investment opportunities, although market conditions and operational challenges must be carefully considered. Jump into the full analysis health report here for a deeper understanding of Ventas. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include NYSE:VTR. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Error while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data
Yahoo
14-05-2025
- Business
- Yahoo
Ventas (NYSE:VTR) Declares Quarterly Dividend of US$0.48 Per Share
Ventas announced a quarterly dividend and reported positive results for the first quarter, reflecting strong financial performance with sales and net income increases compared to the previous year. This announcement came during a period where the broader market, including indices such as the S&P 500 and Nasdaq, experienced a rally; this was largely driven by optimism around U.S.-China tariff reductions and encouraging inflation data. Ventas's price increase of 7% over the last quarter aligns with these market trends, where investor sentiment across various sectors was generally positive, underscoring the company's fiscal health. Every company has risks, and we've spotted 3 risks for Ventas (of which 1 is potentially serious!) you should know about. This technology could replace computers: discover the 22 stocks are working to make quantum computing a reality. The recent announcement of Ventas's quarterly dividend and positive first-quarter earnings highlights its strong financial footing amid broader market recovery. While the 7% share price increase aligns with positive market sentiment, the company's long-term total return of 137.55% over five years provides essential context. This substantial increase underscores Ventas's ability to generate value over extended periods, even as it faces challenges in the senior housing sector. Currently trading at US$65.83, the share price reflects investor confidence, yet it remains below the analyst consensus price target of US$75.95. In comparison to market and industry performance, Ventas's 1-year return surpassed that of both the US market, which returned 11.6%, and the US Health Care REITs industry, which returned 22.4%. This outperformance can be attributed to the company's strategic growth initiatives, including the expansion of its senior housing portfolio and integration of Brookdale communities. Analysts project an 8.8% annual revenue growth, driven by these strategic moves, potentially supporting forecasts of earnings reaching US$495.5 million by 2028. However, reliance on high occupancy rates remains a risk factor, impacting revenue and earnings projections. Ventas's share price movement and analyst forecasts suggest potential investment opportunities, although market conditions and operational challenges must be carefully considered. Jump into the full analysis health report here for a deeper understanding of Ventas. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include NYSE:VTR. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Sign in to access your portfolio
